Related Experiment Video
Updated: Oct 8, 2026

Purification and Visualization of Lipopolysaccharide from Gram-negative Bacteria by Hot Aqueous-phenol Extraction
Published on: May 28, 2012
Inhibition of mouse liver cytochrome P-450 by gram-negative bacteria lipopolysaccharides
1Institute of Microbiology and Immunology, University of Lódź, Banacha, Poland.
Abstract:
The ability of bacterial endotoxins, of different origin, to modify the level of mouse liver cytochrome P-450 was investigated. Endotoxins, (lipopolysaccharides, LPSs) were isolated from Proteus, Escherichia, Salmonella, Bacteroides and Coxiella strains. The most potent inhibitor of cytochrome P-450 activity was S. typhi 0101 LPS, which at a dose of 1 microgram/mouse reduced the cytochrome P-450 activity to 59%. E. coli O55:B5, S. typhimurium, P. mirabilis O3, and C. burnetii LPSs, at dose 10 micrograms/mouse, decrease cytochrome P-450 level from 56 to 69%. B. ovatus LPS significantly suppressed the expression of cytochrome P-450 only at the highest dose used-100 micrograms/mouse. The comparison of inhibitory activity of P. mirabilis complete, S and R types of LPSs indicate that lipid A portion of LPSs are sufficient to decrease the cytochrome P-450 level. However, the core oligosaccharide of LPS significantly enhance that inhibition. The isolated O-specific polysaccharide part of P. mirabilis O3 LPS did not decrease cytochrome P-450 level. The comparison of biological activity of Proteus LPSs, tested by chromogenic Limulus amebocyte lysate (LAL) test, demonstrated the enhancement effect of O-polysaccharide part of tested LPSs.
Insights
Bacterial lipopolysaccharides (LPSs) from various bacteria inhibit mouse liver cytochrome P-450. Salmonella typhi LPS was the most potent inhibitor, significantly reducing P-450 levels.
Area of Science:
- Microbiology
- Biochemistry
- Toxicology
Background:
- Bacterial endotoxins, specifically lipopolysaccharides (LPSs), are known to elicit immune responses.
- Cytochrome P-450 enzymes in the liver are crucial for metabolizing various endogenous and exogenous compounds.
- The impact of different bacterial endotoxins on cytochrome P-450 levels requires further investigation.
Purpose of the Study:
- To investigate the effect of LPSs from different bacterial origins on mouse liver cytochrome P-450 levels.
- To identify which bacterial LPSs are most potent in inhibiting cytochrome P-450 activity.
- To elucidate the role of different LPS structural components in cytochrome P-450 inhibition.
Main Methods:
- Isolation of lipopolysaccharides (LPSs) from various bacterial strains including Proteus, Escherichia, Salmonella, Bacteroides, and Coxiella.
- Administration of varying doses of LPSs to mice.
- Quantification of mouse liver cytochrome P-450 levels.
- Analysis of LPS structural components (Lipid A, core oligosaccharide, O-specific polysaccharide) for inhibitory activity.
Main Results:
- Salmonella typhi 0101 LPS was the most potent inhibitor, reducing cytochrome P-450 to 59% at 1 microgram/mouse.
- LPSs from E. coli, S. typhimurium, P. mirabilis, and C. burnetii decreased cytochrome P-450 levels by 56-69% at 10 micrograms/mouse.
- The Lipid A portion of LPS is sufficient for inhibition, while the core oligosaccharide enhances this effect; the O-specific polysaccharide did not inhibit P-450.
- The O-polysaccharide component enhanced the biological activity of Proteus LPSs in the Limulus amebocyte lysate (LAL) test.
Conclusions:
- Bacterial LPSs exhibit varying degrees of inhibition on mouse liver cytochrome P-450.
- Lipid A is the primary component responsible for LPS-induced P-450 inhibition, with the core oligosaccharide modulating this effect.
- The O-specific polysaccharide may influence LPS biological activity differently, as seen in the LAL test, without directly inhibiting P-450 levels.
Related Concept Videos
Formation of Lipopolysaccharides
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis

